These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 38289855

  • 1. Characterization of cortico-meningeal translocator protein expression in multiple sclerosis.
    Herranz E, Treaba CA, Barletta VT, Mehndiratta A, Ouellette R, Sloane JA, Ionete C, Babu S, Mastantuono M, Magon S, Loggia ML, Makary MM, Hooker JM, Catana C, Kinkel RP, Nicholas R, Klawiter EC, Magliozzi R, Mainero C.
    Brain; 2024 Jul 05; 147(7):2566-2578. PubMed ID: 38289855
    [Abstract] [Full Text] [Related]

  • 2. Neuroinflammatory component of gray matter pathology in multiple sclerosis.
    Herranz E, Giannì C, Louapre C, Treaba CA, Govindarajan ST, Ouellette R, Loggia ML, Sloane JA, Madigan N, Izquierdo-Garcia D, Ward N, Mangeat G, Granberg T, Klawiter EC, Catana C, Hooker JM, Taylor N, Ionete C, Kinkel RP, Mainero C.
    Ann Neurol; 2016 Nov 05; 80(5):776-790. PubMed ID: 27686563
    [Abstract] [Full Text] [Related]

  • 3. A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis.
    Nutma E, Stephenson JA, Gorter RP, de Bruin J, Boucherie DM, Donat CK, Breur M, van der Valk P, Matthews PM, Owen DR, Amor S.
    Brain; 2019 Nov 01; 142(11):3440-3455. PubMed ID: 31578541
    [Abstract] [Full Text] [Related]

  • 4. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Datta G, Colasanti A, Rabiner EA, Gunn RN, Malik O, Ciccarelli O, Nicholas R, Van Vlierberghe E, Van Hecke W, Searle G, Santos-Ribeiro A, Matthews PM.
    Brain; 2017 Nov 01; 140(11):2927-2938. PubMed ID: 29053775
    [Abstract] [Full Text] [Related]

  • 5. Mixed-affinity binding in humans with 18-kDa translocator protein ligands.
    Owen DR, Gunn RN, Rabiner EA, Bennacef I, Fujita M, Kreisl WC, Innis RB, Pike VW, Reynolds R, Matthews PM, Parker CA.
    J Nucl Med; 2011 Jan 01; 52(1):24-32. PubMed ID: 21149489
    [Abstract] [Full Text] [Related]

  • 6. Translocator protein 18 kDa (TSPO) expression in multiple sclerosis patients.
    Harberts E, Datta D, Chen S, Wohler JE, Oh U, Jacobson S.
    J Neuroimmune Pharmacol; 2013 Mar 01; 8(1):51-7. PubMed ID: 22956240
    [Abstract] [Full Text] [Related]

  • 7. Association of Cortical Lesions With Regional Glutamate, GABA, N-Acetylaspartate, and Myoinositol Levels in Patients With Multiple Sclerosis.
    Madsen MA, Považan M, Wiggermann V, Lundell H, Blinkenberg M, Romme Christensen J, Sellebjerg F, Siebner HR.
    Neurology; 2024 Jul 01; 103(1):e209543. PubMed ID: 38870443
    [Abstract] [Full Text] [Related]

  • 8. Cocaine abuse in humans is not associated with increased microglial activation: an 18-kDa translocator protein positron emission tomography imaging study with [11C]PBR28.
    Narendran R, Lopresti BJ, Mason NS, Deuitch L, Paris J, Himes ML, Kodavali CV, Nimgaonkar VL.
    J Neurosci; 2014 Jul 23; 34(30):9945-50. PubMed ID: 25057196
    [Abstract] [Full Text] [Related]

  • 9. Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator Protein.
    Gershen LD, Zanotti-Fregonara P, Dustin IH, Liow JS, Hirvonen J, Kreisl WC, Jenko KJ, Inati SK, Fujita M, Morse CL, Brouwer C, Hong JS, Pike VW, Zoghbi SS, Innis RB, Theodore WH.
    JAMA Neurol; 2015 Aug 23; 72(8):882-8. PubMed ID: 26052981
    [Abstract] [Full Text] [Related]

  • 10. Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [18F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter.
    Sridharan S, Raffel J, Nandoskar A, Record C, Brooks DJ, Owen D, Sharp D, Muraro PA, Gunn R, Nicholas R.
    Mol Imaging Biol; 2019 Oct 23; 21(5):935-944. PubMed ID: 30796709
    [Abstract] [Full Text] [Related]

  • 11. Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [11C]PBR28 positron emission tomography.
    Forsberg A, Lampa J, Estelius J, Cervenka S, Farde L, Halldin C, Lekander M, Olgart Höglund C, Kosek E.
    J Neuroimmunol; 2019 Sep 15; 334():577000. PubMed ID: 31260948
    [Abstract] [Full Text] [Related]

  • 12. TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis.
    Unterrainer M, Mahler C, Vomacka L, Lindner S, Havla J, Brendel M, Böning G, Ertl-Wagner B, Kümpfel T, Milenkovic VM, Rupprecht R, Kerschensteiner M, Bartenstein P, Albert NL.
    Eur J Nucl Med Mol Imaging; 2018 Jul 15; 45(8):1423-1431. PubMed ID: 29523925
    [Abstract] [Full Text] [Related]

  • 13. Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [11 C]PBR28.
    Frankle WG, Narendran R, Wood AT, Suto F, Himes ML, Kobayashi M, Ohno T, Yamauchi A, Mitsui K, Duffy K, Bruce M.
    Synapse; 2017 Jul 15; 71(7):. PubMed ID: 28245513
    [Abstract] [Full Text] [Related]

  • 14. Translocator protein PET imaging for glial activation in multiple sclerosis.
    Oh U, Fujita M, Ikonomidou VN, Evangelou IE, Matsuura E, Harberts E, Fujimura Y, Richert ND, Ohayon J, Pike VW, Zhang Y, Zoghbi SS, Innis RB, Jacobson S.
    J Neuroimmune Pharmacol; 2011 Sep 15; 6(3):354-61. PubMed ID: 20872081
    [Abstract] [Full Text] [Related]

  • 15. Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands.
    Van Weehaeghe D, Babu S, De Vocht J, Zürcher NR, Chew S, Tseng CJ, Loggia ML, Koole M, Rezaei A, Schramm G, Van Damme P, Hooker JM, Van Laere K, Atassi N.
    J Nucl Med; 2020 Nov 15; 61(11):1621-1627. PubMed ID: 32169920
    [Abstract] [Full Text] [Related]

  • 16. Kinetic modelling of [11C]PBR28 for 18 kDa translocator protein PET data: A validation study of vascular modelling in the brain using XBD173 and tissue analysis.
    Veronese M, Reis Marques T, Bloomfield PS, Rizzo G, Singh N, Jones D, Agushi E, Mosses D, Bertoldo A, Howes O, Roncaroli F, Turkheimer FE.
    J Cereb Blood Flow Metab; 2018 Jul 15; 38(7):1227-1242. PubMed ID: 28580888
    [Abstract] [Full Text] [Related]

  • 17. TSPO PET imaging of natalizumab-associated progressive multifocal leukoencephalopathy.
    Mahler C, Schumacher AM, Unterrainer M, Kaiser L, Höllbacher T, Lindner S, Havla J, Ertl-Wagner B, Patzig M, Seelos K, Neitzel J, Mäurer M, Krumbholz M, Metz I, Brück W, Stadelmann C, Merkler D, Gass A, Milenkovic V, Bartenstein P, Albert NL, Kümpfel T, Kerschensteiner M.
    Brain; 2021 Oct 22; 144(9):2683-2695. PubMed ID: 33757118
    [Abstract] [Full Text] [Related]

  • 18. Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis.
    Sucksdorff M, Matilainen M, Tuisku J, Polvinen E, Vuorimaa A, Rokka J, Nylund M, Rissanen E, Airas L.
    Brain; 2020 Dec 05; 143(11):3318-3330. PubMed ID: 33006604
    [Abstract] [Full Text] [Related]

  • 19. Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [(11)C]-PBR28.
    Zürcher NR, Loggia ML, Lawson R, Chonde DB, Izquierdo-Garcia D, Yasek JE, Akeju O, Catana C, Rosen BR, Cudkowicz ME, Hooker JM, Atassi N.
    Neuroimage Clin; 2015 Dec 05; 7():409-14. PubMed ID: 25685708
    [Abstract] [Full Text] [Related]

  • 20. Neuroinflammation in neocortical epilepsy measured by PET imaging of translocator protein.
    Dickstein LP, Liow JS, Austermuehle A, Zoghbi S, Inati SK, Zaghloul K, Zanotti-Fregonara P, Theodore WH.
    Epilepsia; 2019 Jun 05; 60(6):1248-1254. PubMed ID: 31144767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.